Exhibit 99.1
Joint Filing Agreement
The undersigned hereby agree that the Statement on Schedule 13G dated January 15, 2025 with respect to the common stock, par value $0.001 per share, of INmune Bio Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
| Praetorian PR LLC | ||
| By: | /s/ Harris Kupperman | |
| Harris Kupperman, Managing Member | ||
| Date: | 01/15/2025 | |
| Praetorian Capital Fund LLC | ||
| By: | /s/ Harris Kupperman | |
| Harris Kupperman, Managing Member of its Manager | ||
| Date: | 01/15/2025 | |
| Praetorian Capital Management LLC | ||
| By: | /s/ Harris Kupperman | |
| Harris Kupperman, Managing Member | ||
| Date: | 01/15/2025 | |
| Mongolia (Barbados) Corp. | ||
| By: | /s/ Genevieve Walkden | |
| Genevieve Walkden, Chief Financial Officer | ||
| Date: | 01/15/2025 | |
| Mongolia Growth Group Ltd. | ||
| By: | /s/ Harris Kupperman | |
| Harris Kupperman, CEO and Executive Chairman | ||
| Date: | 01/15/2025 | |
| Kupperman Harris | ||
| By: | /s/ Harris Kupperman | |
| Harris Kupperman | ||
| Date: | 01/15/2025 | |
